Detalhe da pesquisa
1.
Alternate aerosol and systemic immunisation with a recombinant viral vector for tuberculosis, MVA85A: A phase I randomised controlled trial.
PLoS Med
; 16(4): e1002790, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31039172
2.
A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA.
N Engl J Med
; 374(17): 1635-46, 2016 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-25629663
3.
Optimization of a Human Bacille Calmette-Guérin Challenge Model: A Tool to Evaluate Antimycobacterial Immunity.
J Infect Dis
; 213(5): 824-30, 2016 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26450421
4.
TB vaccine development: where are we and why is it so difficult?
Thorax
; 70(3): 299-301, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25432943
5.
Inhaled Corticosteroids for Chronic Obstructive Pulmonary Disease--The Shifting Treatment Paradigm.
COPD
; 12(5): 582-90, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25774769
6.
Pulmonary Mycobacterium abscessus: can we identify the road to improved outcomes?
Eur Respir J
; 54(1)2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31296785
7.
Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-escalation, randomised, controlled, phase 1 trial.
Lancet Infect Dis
; 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38621405
8.
Functional in-vitro evaluation of the non-specific effects of BCG vaccination in a randomised controlled clinical study.
Sci Rep
; 12(1): 7808, 2022 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35552463
9.
Induction of Functional Specific Antibodies, IgG-Secreting Plasmablasts and Memory B Cells Following BCG Vaccination.
Front Immunol
; 12: 798207, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35069580
10.
Phase I Trial Evaluating the Safety and Immunogenicity of Candidate TB Vaccine MVA85A, Delivered by Aerosol to Healthy M.tb-Infected Adults.
Vaccines (Basel)
; 9(4)2021 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33923628
11.
A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime - MVA85A boost in healthy UK adults.
Vaccine
; 38(4): 779-789, 2020 01 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31735500
12.
Fungal diseases at the medical front door.
Br J Hosp Med (Lond)
; 80(3): 157-161, 2019 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30860923
13.
Optimisation, harmonisation and standardisation of the direct mycobacterial growth inhibition assay using cryopreserved human peripheral blood mononuclear cells.
J Immunol Methods
; 469: 1-10, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30710562
14.
A first-in-human phase 1 trial to evaluate the safety and immunogenicity of the candidate tuberculosis vaccine MVA85A-IMX313, administered to BCG-vaccinated adults.
Vaccine
; 34(11): 1412-21, 2016 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26854906
15.
A Phase I, Open-Label Trial, Evaluating the Safety and Immunogenicity of Candidate Tuberculosis Vaccines AERAS-402 and MVA85A, Administered by Prime-Boost Regime in BCG-Vaccinated Healthy Adults.
PLoS One
; 10(11): e0141687, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26529238